Author: Hanju Lee


Good News: July 2018

Good News: July 2018

Startup News

  • Gemstone Biotherapeutics Awarded Grant from National Science Foundation
    The Baltimore-based Johns Hopkins spinout committed to developing technologies for skin regeneration was awarded a Phase I Small Business Innovation Research grant by America’s Seed Fund. The program, powered by the National Science Foundation, provides seed money to the most promising science and technology startups across the country.
  • Perceptive Navigation awarded $3M in federal funding
    The Johns Hopkins spinout was awarded the National Institutes of Health Phase IIB Small Business Innovation Research grant to commercialize its ultrasound system that provides medical imaging from within the body. The company will work to further develop the product and conduct studies as it works toward regulatory approval to market its device.
  • Clear Guide Medical gets $2M grant to develop tools for pediatrics
    The Johns Hopkins spinout has received a $2 million grant from the National Institutes of Health to apply its imaging tools to pediatrics. The company’s SCENERGY device is offered as an accessory to ultrasound systems, and helps provide imaging and guidance of a needle during medical procedures like biopsies, epidurals and tissue removal.
  • Maryland companies raised $247M in venture funding during the second quarter of 2018
    Investors have pumped $247 million in venture capital funding into Maryland companies in the second quarter of 2018, including Johns Hopkins startups LifeSprout and WindMIL.
  • Social Innovation Lab alumni named as The Daily Record’s Very Important Professionals
    The newspaper’s annual VIP List honors professionals 40 years of age and younger who have been successful in Maryland. This year’s list featured Shantell L. Roberts, of Touching Young Lives, Incorporated, and Dr. Panagis Galiatsatos, of Medicine for the Greater Good.
  • Hopkins licensee Allakos Inc. announces pricing of its IPO
    The clinical stage biotechnology company announced the pricing of its initial public offering of more than 7.1 million shares of its common stock at a public offering price of $18 per share. Allakos has raised more than $140M in venture funding to advance a pipeline of drug treatment candidates for various gastrointestinal diseases.


Want updates on innovation at Johns Hopkins and in Baltimore? Sign up for our newsletter!


Student Ventures

Johns Hopkins graduate reflects on time with the Commercialization…

Johns Hopkins graduate reflects on time with the Commercialization Academy

Leah Walker is a 2018 Johns Hopkins Bloomberg School of Public Health graduate and a consultant.
Johns Hopkins Bloomberg School of Public Health 2018 graduate Leah Walker is fully engaged in her new role as a consultant in the Greater Boston area. As she reflects on her transition away from academia, the Ph.D. graduate says she partially credits her experience as a member of Johns Hopkins Technology Ventures’ Commercialization Academy for her new role.
The Commercialization Academy, which Walker was chosen to join as an intern in 2016, provides experiential learning opportunities to select graduate and undergraduate students interested in the commercial assessment and marketing of Johns Hopkins technologies. In addition to exposing interns to emerging technologies and commercialization pathways, the program’s curriculum includes networking and career exploration opportunities that relate to the business of science.
“In my third year of the Ph.D. program, I started to look at internship opportunities and learning experiences that would help me reach beyond academic science,” says Walker, who came across the academy through the Johns Hopkins University School of Medicine’s professional development office.
Walker’s thesis focused on the optimization of anti-malarial drugs by improving treatment models of delivering existing drugs with the goal of enhancing efficacy. At the Commercialization Academy, Walker was introduced to industry science and gained a unique knowledge of pharmaceutical partners by sitting in on industry partner meetings and hearing the way they approached problems.
“I found it helpful to talk to people at Tech Ventures with Ph.D.s to see where and how they got where they are now,” says Walker. “I was able to build that network and have exposure to people who have done it before.”
The goal of the Commercialization Academy is to provide scientifically trained graduate students and postdoctoral fellows with commercialization experience that opens opportunities to diverse careers and deepens technically minded undergraduate students’’ relationships with the university while providing a hands-on program that fulfills the institution’’s mission to bring life-changing discoveries to the world .
This idea falls in line with a campus-wide commission spearheaded by Johns Hopkins University President Ronald J. Daniels to try to address the employment challenges faced by most post-docs.
Though many pursue training expecting to secure careers in academia, the majority end up employed outside of it, according to a report by the National Academies of Sciences, Engineering, and Medicine.
Among the recommendations of the commission is to make better data on career paths inside and outside universities available to students and post-doctoral researchers.
Interns in the Commercialization Academy are selected for demonstrating intellectual curiosity that extends beyond their area of expertise, an ability to think abstractly and communicate clearly, a passion for problem solving and persuasive storytelling and the desire to work hard and to receive coaching.
“The Academy teaches interns both how to determine whether a particular technology addresses an unmet need in an industry as well as how to create a value proposition for the same technology that details how it can address this need,” says Benjamin Gibson, who manages the Commercialization Strategy Group of Johns Hopkins Technology Ventures, which employs 10 to 20 interns per year. “The ability to identify and articulate these existing problems and potential solutions is applicable in many different employment fields.”
The program is open to full-time undergraduate students, master’s students, Ph.D. candidates or postdoctoral fellows.
Undergraduate and master’s students accepted into the Commercialization Academy make a two-year commitment. Ph.D. students and postdoctoral fellows must discuss this internship with their PI or faculty mentor before making a commitment, which typically lasts one year.
“It’s a great learning opportunity and career development opportunity for students,” says Walker. “It’s motivating for students and Ph.D. program students to be in a different environment if they don’t want to be on an academic track.”
Applications for the fall cycle will be announced soon. Please visit the Commercialization Academy website for more information about the program and the Fall 2018 application cycle.
Subscribe to the Johns Hopkins Tech Ventures newsletter!

WP-Backgrounds Lite by InoPlugs Web Design and Juwelier Schönmann 1010 Wien